Page last updated: 2024-11-03

propranolol and Acquired Form of Epidermolysis Bullosa

propranolol has been researched along with Acquired Form of Epidermolysis Bullosa in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"Propranolol is an ADRB2 blocker that regulates heart muscle contractions, smooth muscle relaxation, and glycogenolysis."5.56Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita. ( Bieber, K; Ghorbanalipoor, S; Gupta, Y; Hartmann, V; Kaiser, G; Kalies, K; Krause, M; Künzel, S; Ludwig, RJ; Matsumoto, K; Petersen, F; Schulze Dieckhoff, K; Stüssel, P; Veldkamp, W; Vidarsson, G; Visser, R, 2020)
"Propranolol is an ADRB2 blocker that regulates heart muscle contractions, smooth muscle relaxation, and glycogenolysis."1.56Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita. ( Bieber, K; Ghorbanalipoor, S; Gupta, Y; Hartmann, V; Kaiser, G; Kalies, K; Krause, M; Künzel, S; Ludwig, RJ; Matsumoto, K; Petersen, F; Schulze Dieckhoff, K; Stüssel, P; Veldkamp, W; Vidarsson, G; Visser, R, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Stüssel, P1
Schulze Dieckhoff, K1
Künzel, S1
Hartmann, V1
Gupta, Y1
Kaiser, G1
Veldkamp, W1
Vidarsson, G1
Visser, R1
Ghorbanalipoor, S1
Matsumoto, K1
Krause, M1
Petersen, F1
Kalies, K1
Ludwig, RJ1
Bieber, K1
Maglie, R1
Solimani, F1
Quintarelli, L1
Hertl, M1

Other Studies

2 other studies available for propranolol and Acquired Form of Epidermolysis Bullosa

ArticleYear
Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita.
    The Journal of investigative dermatology, 2020, Volume: 140, Issue:12

    Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Animals; Cells, Cultur

2020
Propranolol Off-Target: A New Therapeutic Option in Neutrophil-Dependent Dermatoses?
    The Journal of investigative dermatology, 2020, Volume: 140, Issue:12

    Topics: Animals; Autoantibodies; Collagen Type VII; Epidermolysis Bullosa Acquisita; Humans; Mice; Neutrophi

2020